MARKET

FLNA

FLNA

Filana Therapeutics
NASDAQ
1.210
-0.040
-3.20%
Pre Market: 1.235 +0.025 +2.03% 07:59 06/16 EDT
OPEN
1.260
PREV CLOSE
1.250
HIGH
1.290
LOW
1.170
VOLUME
12.13K
TURNOVER
0
52 WEEK HIGH
4.980
52 WEEK LOW
1.160
MARKET CAP
58.45M
P/E (TTM)
-0.7503
1D
5D
1M
3M
1Y
5Y
1D
Filana Therapeutics Shareholders Back Board, Compensation Plans
TipRanks · 1d ago
Filana Therapeutics shareholders approved 2018 incentive plan amendment at annual meeting
PUBT · 1d ago
Weekly Report: what happened at FLNA last week (0608-0612)?
Weekly Report · 1d ago
Weekly Report: what happened at FLNA last week (0601-0605)?
Weekly Report · 06/08 09:34
Weekly Report: what happened at FLNA last week (0525-0529)?
Weekly Report · 06/01 09:37
BridgeBio, Dave, Marvell, Filana, GE Trending With Analysts
TipRanks · 05/30 09:01
Filana Therapeutics posts Eilat XVIII scientific presentation on simufilam in TSC seizures
PUBT · 05/27 21:43
Filana Therapeutics Price Target Announced at $5.00/Share by Maxim Group
Dow Jones · 05/26 20:02
More
About FLNA
Filana Therapeutics, Inc., formerly Cassava Sciences, Inc., is a clinical-stage biotechnology company focused on developing novel, investigational treatments for central nervous system disorders, including Alzheimer’s disease and tuberous sclerosis complex (TSC)-related seizures. The Company's science is based on stabilizing, but not removing, a critical protein in the brain for patients with disorders such as Alzheimer’s disease or TSC. It has two biopharmaceutical assets under development: Simufilam and SavaDx. Simufilam, its lead therapeutic product candidate, is an oral treatment for Alzheimer’s disease and TSC-related epilepsy. Simufilam targets an altered form of a protein called filamin A (FLNA) in the brain of patients with disorders such as Alzheimer’s disease or TSC. SavaDx, its lead investigational diagnostic product candidate, is an early-stage program focused on detecting the presence of Alzheimer’s disease from a small sample of blood.

Webull offers Filana Therapeutics Inc stock information, including NASDAQ: FLNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FLNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FLNA stock methods without spending real money on the virtual paper trading platform.